ClinicalTrials.gg
RecruitingNCT06862895Updated Mar 6, 2025

Effect of Chest Physiotherapy on Clinical Outcome of Infants With Bronchiolitis

An interventional study of chest physiotherapy in Bronchiolitis, Infant, Newborn, Diseases and Chest Physiotherapy, sponsored by Hawler Medical University. Recruiting at 1 site in Iraq. Open to participants aged 1 Month to 1 Year. Per ClinicalTrials.gov, last updated 2025-03-06.

Sponsored by Hawler Medical University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
1 Month to 1 Year
Sex
All
01

Study summary

The goal of clinical trial study is to evaluate effect of chest physiotherapy educational on mother's knowledge, practice and clinical outcomes of infants aged less than 12 months diagnosed with bronchiolitis by physician

The main questions aims to answer:

  • Does chest physiotherapy improve clinical outcomes of infants with bronchiolitis?
  • Does educational program improve mothers knowledge and practice regarding chest physiotherapy?

Researcher compare two groups one receive routine hospital care (control group) other receive chest physiotherapy applied by mothers in addition to routine hospital care and will be followed up for 3 days

02

Conditions studied

  • Bronchiolitis
  • Infant, Newborn, Diseases
  • Chest Physiotherapy
  • Educational Program
03

In context

Bronchiolitis

289 studies on the registry are indexed under Bronchiolitis; 51 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 195 interventional studies indexed under Bronchiolitis.

Browse Bronchiolitis studies →

Lead sponsor

Hawler Medical University is the lead sponsor of 59 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 1 Year
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. Mothers of infants diagnosed with bronchiolitis. 2. Presence of crackle on auscultation.

Exclusion criteria

Exclusion Criteria:

  1. Children with of chest physiotherapy (ex. Fracture, recent surgery)
  2. Children who intubated and admitted to Intensive Care Unit (ICU).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    intervention group

    chest physiotherapy

    Other: chest physiotherapy

  • No intervention
    control group

    no intervention

Interventions

  • Otherchest physiotherapy

    Chest Physiotherapy is including various techniques, in this study classical CPT was used to be applied to participants

06

What researchers measure

Primary outcomes

  1. change in Clinical Outcomes of Infants with Bronchiolitis

    changing of oxygen saturation( SPO2) \<90% to normal level SPO2\>92%

    Time frame: baseline

  2. change in physiological outcomes of Infants with Bronchiolitis

    change in respiratory rate from abnormal to normal (0-3 month RR:35-55 3-6 month RR:30-45 6-12 month RR:25-40) breath per minute

    Time frame: baseline

Secondary outcomes

  1. Improvement in Knowledge of Mother's

    after application of educational program expected to to improve mother's knowledge regarding chest physiotherapy

    Time frame: After 3 days

  2. Improvement in practices of Mother's

    after application of educational program expected to to improve mother's practice regarding chest physiotherapy

    Time frame: After 3 days

07

Study locations

1 of 1 sites recruiting
  • Hawler Medical University
    Erbil, Kurdistan 61002, Iraq
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Feb 2025, 1 month.

Of 54 non-industry interventional studies with no phase under Bronchiolitis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 1 month is below that.

Counting every sponsor, half of 57 studies reached it within 22 months; a quarter within 11 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2025
First posted
Mar 6, 2025
StartActual
Jan 1, 2025
Primary completionActual
Feb 1, 2025
CompletionEst.
Sep 1, 2025
Last update
Mar 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06862895
Lead sponsor
Hawler Medical University
Responsible party
Shaimaa Shwan (principal Investigator, Hawler Medical University) — Principal investigator
First posted
Mar 6, 2025
Start date
Jan 1, 2025
Primary completion
Feb 1, 2025
Completion
Sep 1, 2025 (estimated)
Last update
Mar 6, 2025

Study contacts

Nazar Othman, Assist.Prof
Contact
nazar.othman@hmu.edu.krd
750 494 6398 ext. +964

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion